126 related articles for article (PubMed ID: 38908355)
1. Melanoma Deaths by Thickness: Most Melanoma Deaths Are Not Attributable to Thin Melanomas.
Stephens KR; Donica WRF; Philips P; McMasters KM; Egger ME
J Surg Res; 2024 Jun; 301():24-28. PubMed ID: 38908355
[TBL] [Abstract][Full Text] [Related]
2. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
Lo SN; Scolyer RA; Thompson JF
Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716
[TBL] [Abstract][Full Text] [Related]
4. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
6. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
7. Melanoma incidence and Breslow tumour thickness development in the central Alpine region of South Tyrol from 1998 to 2012: a population-based study.
Ambrosini-Spaltro A; Dal Cappello T; Deluca J; Carriere C; Mazzoleni G; Eisendle K
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):243-248. PubMed ID: 24684396
[TBL] [Abstract][Full Text] [Related]
8. Proportion of Thick versus Thin Melanomas as a Benchmarking Tool.
Pagliarello C; Magi S; Mazzoni L; Stanganelli I
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884250
[TBL] [Abstract][Full Text] [Related]
9. The Burden of Thin Melanomas in Tuscany, Italy, 1985-2017: Age- and Sex-Specific Temporal Trends in Incidence and Mortality.
Manneschi G; Caldarella A; Caini S; Checchi S; Intrieri T; Chiarugi A; Nardini P; Masala G
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339287
[TBL] [Abstract][Full Text] [Related]
10. Differences in Thickness-Specific Incidence and Factors Associated With Cutaneous Melanoma in the US From 2010 to 2018.
Chen ML; de Vere Hunt IJ; John EM; Weinstock MA; Swetter SM; Linos E
JAMA Oncol; 2022 May; 8(5):755-759. PubMed ID: 35323844
[TBL] [Abstract][Full Text] [Related]
11. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
12. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
Claeson M; Gillstedt M; Whiteman DC; Paoli J
Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
[TBL] [Abstract][Full Text] [Related]
13. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
14. Thin melanoma.
Elder DE
Arch Pathol Lab Med; 2011 Mar; 135(3):342-6. PubMed ID: 21366458
[TBL] [Abstract][Full Text] [Related]
15. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Study of Diameter and Breslow Thickness in Invasive Melanomas.
Dessinioti C; Plaka M; Befon A; Polidorou D; Stefanaki I; Kypreou K; Theology V; Stratigos AJ
Dermatology; 2024; 240(3):462-467. PubMed ID: 38290473
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma.
Claeson M; Baade P; Brown S; Soyer HP; Smithers BM; Green AC; Whiteman DC; Khosrotehrani K
Br J Dermatol; 2020 Apr; 182(4):927-931. PubMed ID: 31562769
[TBL] [Abstract][Full Text] [Related]
18. Reflectance confocal microscopy features of thin versus thick melanomas.
Kardynal A; Olszewska M; de Carvalho N; Walecka I; Pellacani G; Rudnicka L
G Ital Dermatol Venereol; 2019 Aug; 154(4):379-385. PubMed ID: 29368860
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of XIAP in melanoma.
Emanuel PO; Phelps RG; Mudgil A; Shafir M; Burstein DE
J Cutan Pathol; 2008 Mar; 35(3):292-7. PubMed ID: 18251743
[TBL] [Abstract][Full Text] [Related]
20. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
